Neurocognitive Impairment in Non-Central Nervous System Cancer Survivors

被引:1
|
作者
Schoenberg, Poppy L. A. [1 ,2 ]
Mohr, Emily M. [2 ]
Kilpatrick, Phyllis E. [3 ]
Murphy, Barbara A. [3 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Phys Med & Rehabil, Nashville, TN 37203 USA
[2] Vanderbilt Univ, Med Ctr, Osher Ctr Integrat Hlth, 3401 West End,Suite 380, Nashville, TN 37203 USA
[3] Vanderbilt Ingram Canc Ctr, Div Hematol & Oncol, Nashville, TN USA
关键词
cancer; neurocognitive impairment; electrophysiology; ERPs; executive function; EVENT-RELATED POTENTIALS; COGNITIVE THERAPY; NECK-CANCER; HEAD; PERFORMANCE; MODULATION; COMPONENT; INDEX; ERPS; N1;
D O I
10.1027/0269-8803/a000326
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Cancer and its treatments entail a profound inflammatory response of the central nervous system (CNS). This intense neurotoxic process can lead to significant neurocognitive impairment even in non-CNS cancers. Few studies have examined this domain, and data available is based on limited designs using neuropsychological assessments comprising self-report or traditional testing batteries that capture basic response data. Here, we leverage cognitive electrophysiology, specifically Event-Related Potentials (ERPs), to examine and delineate neurocognitive impairments in non-CNS cancer survivors. Eleven survivors, who were on average 4.6 years in remission from head and neck cancer and 10 matched healthy controls underwent standardized cognitive and emotional "Go-Nogo" paradigms concomitant to EEG recording. Significant differences in amplitude morphology in the very early ERP components (C1, N1, P1) and middle ERP component (N2), were apparent between non-CNS cancer survivors and controls. Later ERP components (P3, N4) did not show amplitude differences. Non-CNS cancer survivors yielded faster latencies in the early components for pain-related stimuli during the emotional paradigm, albeit tended to yield slower ERP latencies overall across both experiments. These findings suggest that early gating and inhibitory control are dysregulated in non-CNS cancer survivors, which can impact executive functioning and cognitive processing involved in everyday activities for many years post-treatment. The findings do not fully align with ERP morphologies associated with neurocognitive impairment in degenerative conditions (such as dementia and Alzheimer's disease), affecting later-stage ERP components. Our initial results suggest that (1) cognitive impairments in cancer survivors do not follow a degenerative trajectory, (2) rather are in line with "lesion" related damage (such as stroke, epilepsy), and as such, (3) have the potential for treatments involving neurocognitive plasticity.
引用
收藏
页码:11 / 27
页数:17
相关论文
共 50 条
  • [1] Cancer-related cognitive impairment in survivors of adolescent and young adult non-central nervous system cancer: A scoping review
    Vizer, Lisa M.
    Mikles, Sean P.
    Piepmeier, Aaron T.
    PSYCHO-ONCOLOGY, 2022, 31 (08) : 1275 - 1285
  • [2] Neuropsychological Sequelae of Non-Central Nervous System Cancer and Cancer Therapy
    Jeffrey S. Wefel
    Mariana E. Witgert
    Christina A. Meyers
    Neuropsychology Review, 2008, 18 : 121 - 131
  • [3] Neuropsychological sequelae of non-central nervous system cancer and cancer therapy
    Wefel, Jeffrey S.
    Witgert, Mariana E.
    Meyers, Christina A.
    NEUROPSYCHOLOGY REVIEW, 2008, 18 (02) : 121 - 131
  • [4] Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options
    Di Iulio, Fulvia
    Cravello, Luca
    Shofany, Jacob
    Paolucci, Stefano
    Caltagirone, Carlo
    Morone, Giovanni
    NEUROLOGICAL SCIENCES, 2019, 40 (09) : 1759 - 1774
  • [5] Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review
    Oppegaard, Kate R.
    Armstrong, Terri S.
    Anguera, Joaquin A.
    Kober, Kord M.
    Kelly, Debra Lynch
    Laister, Rob C.
    Saligan, Leorey N.
    Ayala, Ana Patricia
    Kuruvilla, John
    Alm, Mark W.
    Byker, William H.
    Miaskowski, Christine
    Mayo, Samantha J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 180
  • [6] Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy
    Noemí Cerulla Torrente
    José-Blas Navarro Pastor
    Nuria de la Osa Chaparro
    Journal of Cancer Survivorship, 2020, 14 : 464 - 482
  • [7] Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy
    Cerulla Torrente, Noemi
    Navarro Pastor, Jose-Blas
    de la Osa Chaparro, Nuria
    JOURNAL OF CANCER SURVIVORSHIP, 2020, 14 (04) : 464 - 482
  • [8] Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options
    Fulvia Di Iulio
    Luca Cravello
    Jacob Shofany
    Stefano Paolucci
    Carlo Caltagirone
    Giovanni Morone
    Neurological Sciences, 2019, 40 : 1759 - 1774
  • [9] Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group
    Mayo, Samantha J.
    Lustberg, Maryam
    M. Dhillon, Haryana
    Nakamura, Zev M.
    Allen, Deborah H.
    Von Ah, Diane
    C. Janelsins, Michelle
    Chan, Alexandre
    Olson, Karin
    Tan, Chia Jie
    Toh, Yi Long
    Oh, Jeong
    Grech, Lisa
    Cheung, Yin Ting
    Subbiah, Ishwaria Mohan
    Petranovic, Duska
    D'Olimpio, James
    Gobbo, Margherita
    Koeppen, Susanne
    Loprinzi, Charles L.
    Pang, Linda
    Shinde, Shivani
    Ntukidem, Olanipekun
    Peters, Katherine B.
    SUPPORTIVE CARE IN CANCER, 2021, 29 (06) : 2821 - 2840
  • [10] Prognostic factors and survival in non-central nervous system rhabdoid tumors
    Farber, Benjamin A.
    Shukla, Neerav
    Lim, Irene Isabel P.
    Murphy, Jennifer M.
    La Quaglia, Michael P.
    JOURNAL OF PEDIATRIC SURGERY, 2017, 52 (03) : 373 - 376